The role of the intestinal tract as a source for transmission of nosocomial pathogens
Tóm tắt
Từ khóa
Tài liệu tham khảo
Donskey CJ: The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004, 39:219–226.
Donskey CJ, Chowdhry TK, Hecker MT, et al.: Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000, 343:1925–1932. This is a prospective study demonstrating that antianaerobic antibiotics promote persistent overgrowth of VRE in the stool of colonized patients.
Cole GT, Halawa AA, Anaissie EJ: The role of the gastrointestinal tract in hematogenous dissemination of candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996, 22(Suppl 2):S73-S88.
Hoyen CK, Pultz NJ, Paterson DL, et al.: Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2003, 47:3610–3612.
Bhalla A, Pultz NJ, Ray AJ, et al.: Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant gramnegative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 2003, 24:644–649.
Ray AJ, Pultz NJ, Bhalla A, et al.: Coexistence of vancomycinresistant Enterococcus and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003, 37:875–881. This is a prospective study demonstrating that VRE and S. aureus frequently coexist in the intestinal tract, providing a potential reservoir for emergence of VRSA isolates. The literature regarding the epidemiology and pathogenesis of S. aureus intestinal colonization is reviewed.
Safdar N, Maki DG: The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002, 136:834–844.
Donskey CJ, Ray AJ, Hoyen CK, et al.: Co-colonization and infection with multiple nosocomial pathogens in patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2003, 24:242–245.
Bhalla A, Pultz NJ, Ray AJ, et al.: Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004, 25:164–167.
Wilcox MH, Fawley WN, Wigglesworth N, et al.: Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003, 54:109–114.
Leibovitz A, Dan M, Zinger J, et al.: Pseudomonas aeruginosa and oropharyngeal ecosystem of tube-fed patients. Emerg Infect Dis 2003, 9:956–959.
Brooks S, Khan A, Stoica D, et al.: Reduction in vancomycinresistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol 1998, 19:333–336.
Ray AJ, Donskey CJ: Clostridium difficile infection and concurrent vancomycin-resistant Enterococcus stool colonization in a health care worker: case report and review of the literature. Amer J Infect Control 2003, 31:54–56.
Guerrant RL: Principles and syndromes of enteric infection. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, vol 2, edn 4. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone; 1995:2195–2204.
Cunningham R, Dale B, Undy B, et al.: Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003, 54:243–245.
Cordonnier C, Buzyn A, Leverger G, et al.: Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003, 36:149–158.
Sullivan A, Edlund C, Nord CE: Effect of antimicrobial agents on the ecological balance of human microbiota. Lancet Infect Dis 2001, 1:101–114. This is an excellent review of current data regarding the effects of antibiotic treatment on indigenous intestinal microflora.
Boyce JM, Opal SM, Chow JW, et al.: Outbreak of multidrugresistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994, 32:1148–1153.
Mayer RA, Geha RC, Helfand MS, et al.: The role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococci. Amer J Infect Control 2003, 31:221–225.
Gerding DN: Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004, 38:646–648.
Johnson S, Samore MH, Farrow KA, et al.: Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999, 341:1645–1651.
Stiefel U, Pultz NJ, Helfand MS, et al.: Increased susceptibility to establishment of vancomycin-resistant Enterococcus intestinal colonization persists after completion of antianaerobic antibiotic treatment in mice. Infect Control Hosp Epidemiol 2004, 25:373–379.
Samonis G, Anaissie EJ, Bodey GP: Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother 1990, 34:2420–2422.
Samonis G, Gikas A, Anaissie EJ, et al.: Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993, 37:51–53.
Rimland D, Roberson BE: Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1986, 24:137–138.
Squier C, Rihs JD, Risa KJ, et al.: Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002, 23:495–501.
Boyce JM: Nosocomial antibiotic-associated diarrhea (AAD) caused by methicillin-resistant Staphylococcus aureus (MRSA) [abstract 270]. Program and Abstracts of the 13th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. Arlington, VA; 2003.
Silvestri L, Milanese M, Oblach L, et al.: Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002, 30:391–399.
Maraha B, van Halteren J, Verzijl JM, et al.: Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin. Clin Microbiol Infect 2002, 8:671–675.
Boyce JM, Pitet D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force: Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 2002, 30:S1-S46.
Muto CA, Jernigan JA, Ostrowsky BE, et al.: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003, 24:362–386.
Srinivasan A, Song X, Ross T, et al.: A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002, 23:424–428.
Hecker MT, Aron DC, Patel NP, et al.: Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003, 163:972–978.
Paterson DL, Ndirangu M, Clarke L, et al.: Relative "collateral damage" caused by piperacillin/tazobactam and cefepime in patients treated in the intensive care unit [abstract K-1418]. Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2003.
Harris AD, Bradham DD, Baumgarten M, et al.: The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 2004, 38:1586–1591. This is an excellent review of the benefits and limitations of quasi-experimental (nonrandomized, pre- and postintervention) studies. Such study designs are frequently used to evaluate the effect of formulary interventions on rates of colonization and infection with nosocomial pathogens.
Stiefel U, Paterson DL, Pultz NJ, et al.: Effect of increasing use of piperacillin/tazobactam on the incidence of vancomycinresistant enterococci in four academic medical centers. Infect Control Hosp Epidemiol 2004, 25:380–383.
De Jonge E, Schultz MJ, Spanjaard L, et al.: Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet 2003, 362:1011–1016.
Vincent JL: Selective digestive contamination: for everyone, everywhere? Lancet 2003, 362:1006–1007.
Stiefel U, Pultz NJ, Helfand MS, Donskey CJ: Efficacy of oral ramoplanin for inhibition of vancomycin-resistant Enterococcus intestinal colonization in mice. Antimicrob Agents Chemother 2004, 48:2144–2148.
Vernon MO, Blom DW, Hayes RA, et al.: Efficacy of a chlorhexidene gluconate body cleanser for reducing skin contamination with vancomycin-resistant enterococci among intensive care unit patients [abstract K-1108]. Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2003.
Wilson M: Light-activated antimicrobial coating for the continuous disinfection of surfaces. Infect Control Hosp Epidemiol 2003, 24:782–784.